As of 2026-06-07, the EV/EBITDA ratio of Wuhan Keqian Biology Co Ltd (688526.SS) is 16.50. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 688526.SS's latest enterprise value is 5,851.61 mil CNY. 688526.SS's TTM EBITDA according to its financial statements is 354.59 mil CNY. Dividing these 2 quantities gives us the above 688526.SS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 39.6x | 28.2x |
| Forward P/E multiples | 9.4x - 10.4x | 9.9x |
| Fair Price | 12.76 - 30.08 | 17.43 |
| Upside | 1.8% - 139.9% | 39.0% |
| Date | EV/EBITDA |
| 2026-06-05 | 16.50 |
| 2026-06-04 | 16.46 |
| 2026-06-03 | 16.88 |
| 2026-06-02 | 17.19 |
| 2026-06-01 | 17.46 |
| 2026-05-29 | 17.30 |
| 2026-05-28 | 17.16 |
| 2026-05-27 | 17.32 |
| 2026-05-26 | 17.94 |
| 2026-05-25 | 18.67 |
| 2026-05-22 | 18.68 |
| 2026-05-21 | 18.83 |
| 2026-05-20 | 19.04 |
| 2026-05-19 | 19.09 |
| 2026-05-18 | 18.93 |
| 2026-05-15 | 19.37 |
| 2026-05-14 | 19.14 |
| 2026-05-13 | 19.43 |
| 2026-05-12 | 19.45 |
| 2026-05-11 | 19.78 |
| 2026-05-08 | 19.58 |
| 2026-05-07 | 19.35 |
| 2026-05-06 | 19.28 |
| 2026-04-30 | 18.96 |
| 2026-04-29 | 19.32 |
| 2026-04-28 | 19.12 |
| 2026-04-27 | 19.25 |
| 2026-04-24 | 19.43 |
| 2026-04-23 | 19.58 |
| 2026-04-22 | 19.82 |
| 2026-04-21 | 19.80 |
| 2026-04-20 | 19.85 |
| 2026-04-17 | 19.87 |
| 2026-04-16 | 20.01 |
| 2026-04-15 | 19.96 |
| 2026-04-14 | 19.83 |
| 2026-04-13 | 19.50 |
| 2026-04-10 | 19.80 |
| 2026-04-09 | 19.60 |
| 2026-04-08 | 20.04 |
| 2026-04-07 | 19.75 |
| 2026-04-03 | 19.26 |
| 2026-04-02 | 19.68 |
| 2026-04-01 | 19.58 |
| 2026-03-31 | 19.11 |
| 2026-03-30 | 19.20 |
| 2026-03-27 | 19.34 |
| 2026-03-26 | 19.14 |
| 2026-03-25 | 19.30 |
| 2026-03-24 | 19.12 |